More about

Psoriasis

News
October 11, 2019
4 min read
Save

4-year data demonstrate safety, efficacy of Ilumya in plaque psoriasis

4-year data demonstrate safety, efficacy of Ilumya in plaque psoriasis

The safety and efficacy of Ilumya were maintained after 4 years of treatment among patients with plaque psoriasis enrolled in the open-label reSURFACE1 trial, according to data presented at the European Academy of Dermatology and Venereology Congress.

News
October 11, 2019
2 min read
Save

Psoriasis severity affects severity of nonalcoholic fatty liver disease

Prospective study data presented at the European Academy of Dermatology and Venereology Congress demonstrated that psoriasis severity is associated with more severe hepatic damage among patients with both psoriasis and nonalcoholic fatty liver disease. Specifically, an increase in PASI score by one was associated with an increase in elastography of, on average, 0.26 kPa.

News
October 10, 2019
1 min read
Save

Patients overpay more for brand-name topical dermatologic drugs

Among topical dermatologic drugs, the mean overpayment for brand-name drugs was more than double that of generics, based on an analysis of claims data of privately insured individuals published in JAMA Dermatology.

News
October 08, 2019
2 min read
Save

Greater QoL, pain improvement in psoriasis with phototherapy vs. adalimumab

Adalimumab and phototherapy for psoriasis are both associated with statistically significant improvements in patient-reported outcomes after 12 weeks, but phototherapy yields greater improvement in quality of life and pain, according to recent study findings.

News
October 08, 2019
1 min read
Save

South Beach Symposium hosts renowned faculty, interactive learning

Dermatology is gearing up for the upcoming South Beach Symposium in Miami Beach, Florida, Feb. 6-9, 2020.

News
October 07, 2019
1 min read
Save

Taltz superior to Tremfya for complete skin clearance at 12 weeks

Eli Lilly and Co. reported that its phase 4 study, IXORA-R, met the primary endpoint of patients treated with Taltz showing statistically significant improvement in the Psoriasis Area Severity Index 100 score compared with patients on Tremfya at week 12.

News
October 03, 2019
2 min read
Save

University of Michigan offers unique resources for inflammatory skin disease research

University of Michigan offers unique resources for inflammatory skin disease research

The department of dermatology at the University of Michigan Medical School has been awarded $3.9 million from the NIH to establish the University of Michigan Skin Biology and Diseases Resource-based Center to foster interdisciplinary collaboration, according to a university press release.

News
October 01, 2019
1 min read
Save

Metabolic syndrome does not hinder Ilumya efficacy in psoriasis

Metabolic syndrome status does not affect Ilumya efficacy, safety or drug survival in patients with moderate to severe chronic psoriasis, according to post hoc analyses from two phase 3 studies, reSURFACE 1 and 2.

News
September 30, 2019
9 min read
Save

Experts: Be proactive about family planning for women with chronic rheumatic diseases

Experts: Be proactive about family planning for women with chronic rheumatic diseases

Researchers discovered differences in clinical support and patient education among women of childbearing age with chronic rheumatic diseases in Asia-Pacific and Europe, from a study presented at European League Against Rheumatism.

News
September 30, 2019
1 min read
Save

Skin cancer biopsy rates among providers, top dermatology stories

Dermatologists performed the fewest number of biopsies to diagnose one skin cancer compared with other types of clinicians, according to researchers from University of Wisconsin-Madison and Mayo Clinic, in the top Healio Dermatology story last week.

View more